Synopsis
Synopsis
0
USDMF
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 61438-64-0
2. Closantel (sodium)
3. 0zbs9yc04p
4. 61438-64-0 (sodium)
5. Sodium 2-((5-chloro-4-((4-chlorophenyl)(cyano)methyl)-2-methylphenyl)carbamoyl)-4,6-diiodophenolate
6. Unii-0zbs9yc04p
7. Einecs 262-794-7
8. Hms3652m14
9. Hy-17596a
10. Akos015894903
11. Ccg-270373
12. Cs-3976
13. Ks-1256
14. Sodium N-(5-chloro-4-((4-chlorophenyl)cyanomethyl)-o-tolyl)-2-hydroxy-3,5-diiodobenzamidate
15. Sw219512-1
16. C75881
17. R-34828
18. Q27251068
19. 5'-chloro-4'-(4-chloro-.alpha.-cyanobenzyl)-3,5-di-iodosalicyl-o-toluidide
20. Benzamide, N-(5-chloro-4-((4-chlorophenyl)cyanomethyl)-2-methylphenyl)-2-hydroxy-3,5-diiodo-, Monosodium Salt
21. N-[5-chloro-4-[(4-chlorophenyl)cyanomethyl]-2-methylphenyl]-3,5-diiodo-2-(sodiooxy)benzamide
22. Sodium 2-(5-chloro-4-((4-chlorophenyl)(cyano)methyl)-2-methylphenylcarbamoyl)-4,6-diiodophenolate
23. Sodium;2-[[5-chloro-4-[(4-chlorophenyl)-cyanomethyl]-2-methylphenyl]carbamoyl]-4,6-diiodophenolate
| Molecular Weight | 685.1 g/mol |
|---|---|
| Molecular Formula | C22H13Cl2I2N2NaO2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 4 |
| Exact Mass | 683.83412 g/mol |
| Monoisotopic Mass | 683.83412 g/mol |
| Topological Polar Surface Area | 76 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 659 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Closantel Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Closantel Sodium, including repackagers and relabelers. The FDA regulates Closantel Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Closantel Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Closantel Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Closantel Sodium supplier is an individual or a company that provides Closantel Sodium active pharmaceutical ingredient (API) or Closantel Sodium finished formulations upon request. The Closantel Sodium suppliers may include Closantel Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Closantel Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Closantel Sodium CEP of the European Pharmacopoeia monograph is often referred to as a Closantel Sodium Certificate of Suitability (COS). The purpose of a Closantel Sodium CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Closantel Sodium EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Closantel Sodium to their clients by showing that a Closantel Sodium CEP has been issued for it. The manufacturer submits a Closantel Sodium CEP (COS) as part of the market authorization procedure, and it takes on the role of a Closantel Sodium CEP holder for the record. Additionally, the data presented in the Closantel Sodium CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Closantel Sodium DMF.
A Closantel Sodium CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Closantel Sodium CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Closantel Sodium suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Closantel Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Closantel Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Closantel Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Closantel Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Closantel Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Closantel Sodium suppliers with NDC on PharmaCompass.
Closantel Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Closantel Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Closantel Sodium GMP manufacturer or Closantel Sodium GMP API supplier for your needs.
A Closantel Sodium CoA (Certificate of Analysis) is a formal document that attests to Closantel Sodium's compliance with Closantel Sodium specifications and serves as a tool for batch-level quality control.
Closantel Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Closantel Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Closantel Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Closantel Sodium EP), Closantel Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Closantel Sodium USP).
LOOKING FOR A SUPPLIER?
